News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Retatrutide poised to be the next weight-loss option for T2D with obesity
24 Oct 2026
byElvira Manzano
In the phase III TRIUMP-2 trial, retatrutide improves glycaemic control and reduces body weight in adults with type 2 diabetes (T2D) who are overweight or have obesity, potentially expanding weight-loss options for this population.
24 Oct 2026

ARCADIA LTE supports long-term efficacy, safety of nemolizumab for AD
23 Oct 2026
byAudrey Abella
The open-label long-term extension (LTE) of the ARCADIA trial demonstrates the safety and efficacy of nemolizumab for up to 152 weeks in adults and adolescents with moderate-to-severe atopic dermatitis (AD).
23 Oct 2026






